Citadel Advisors
BKYI

Citadel Advisors’s BIO-key International BKYI Stock Holding History

Citadel Advisors’s Portfolio BKYI Stock Details BKYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1
Closed -$52 – 14290
2023
Q3 		$52 Sell
1
-5
-83% -$568 ﹤0.01% 14182
2023
Q2 		$769 Buy
+6
New +$798 ﹤0.01% 14050
2023
Q1 		– Sell
-28
Closed -$2.92K – 14724
2022
Q4 		$2.92K Buy
+28
New +$6.09K ﹤0.01% 14270
2022
Q3 		– Sell
-116
Closed -$37K – 12624
2022
Q2 		$37K Sell
116
-1
-0.9% -$355 ﹤0.01% 12112
2022
Q1 		$51K Sell
117
-123
-51% -$49.7K ﹤0.01% 12774
2021
Q4 		$95K Sell
240
-402
-63% -$203K ﹤0.01% 12767
2021
Q3 		$407K Sell
642
-218
-25% -$129K ﹤0.01% 10364
2021
Q2 		$588K Sell
860
-81
-9% -$53.2K ﹤0.01% 9669
2021
Q1 		$591K Buy
+941
New +$679K ﹤0.01% 9316

Other funds holding BKYI

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Citadel Advisors's BKYI Position: Q1 2026 in Review

Citadel Advisors sold out of BIO-key International (BKYI) in Q1 2026, closing a stake of 3,164 shares — an estimated $17.1K sold.

Citadel Advisors first reported a position in BKYI in Q1 2019 and held it in 14 quarters. The position peaked at $80K in Q4 2020. 10 funds tracked by Wall St. Rank hold BKYI as of Q1 2026.

  • Citadel Advisors reported no remaining BIO-key International position as of Q1 2026 after selling out during the quarter.
  • Citadel Advisors sold 3,164 BIO-key International shares in Q1 2026, an estimated $17.1K.
  • Citadel Advisors first reported a position in BIO-key International in Q1 2019 and held it in 14 quarters.
  • Citadel Advisors's BIO-key International position peaked at $80K in Q4 2020.
  • 10 funds tracked by Wall St. Rank held BIO-key International as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.